Posterior-scleritis: Case report of an uncommon immune-related adverse event in the treatment of advanced endometrial cancer

Posterior-scleritis: Case report of an uncommon immune-related adverse event in the treatment of advanced endometrial cancer

As Immune checkpoint inhibitors are being expanded for use in gynecologic malignancies, rare immune-related adverse events are more frequently being reported. Here we describe a 63-year-old with Stage IIIB mismatch repair deficient uterine adenocarcinoma who underwent six cycles of carboplatin and p...

Full description

Bibliographic Details
Main Authors: Brandon I. Ing, Derek Kuhl, Deanna Glassman, Cynae A. Johnson, Shrina Patel, Amir A. Jazaeri
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Gynecologic Oncology Reports
Subjects:
Pembrolizumab
Immune-related
Endometrial cancer
Immunotherapy toxicity
Immune checkpoint inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578923003132

Similar Items

Similar Items